Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-05-21

Clinical Trial Update: Sirolimus With corTicOsteroid TheraPy for Rapid rEcurrences of Coronary Unexplained In-stent Restenosis [NA]

View source ↗

Summary

A clinical trial update describes testing sirolimus with corticosteroid therapy to address rapid recurrences of coronary unexplained in-stent restenosis; the st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Corticosteroid therapy (corticosteroid)
  • Sirolimus (Sirolimus)

Snippet

Sponsor: China National Center for Cardiovascular Diseases | Conditions: In-stent Restenosis Lesion, Coronary Artery Disease (CAD) (E.G., Angina, Myocardial Infarction, and Atherosclerotic Heart Disease (ASHD)) | NA | Status: NOT_YET_RECRUITING